C
C. Lenaerts
Researcher at Université de Montréal
Publications - 20
Citations - 689
C. Lenaerts is an academic researcher from Université de Montréal. The author has contributed to research in topics: Liver disease & Cirrhosis. The author has an hindex of 12, co-authored 20 publications receiving 663 citations.
Papers
More filters
Journal ArticleDOI
High Incidence of Upper Gastrointestinal Tract Involvement in Children With Crohn Disease
TL;DR: Because upper gastrointestinal series x-ray studies failed to detect upper gastrointestinal lesions in 13 patients of 69 of those with upper gastrointestinal disease, endoscopy should be considered in all children and adolescents in whom a diagnosis of Crohn disease is entertained.
Journal ArticleDOI
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
Frédéric Gottrand,Nicolas Kalach,Claire Spyckerelle,Dominique Guimber,Jean-François Mougenot,Patrick Tounian,C. Lenaerts,Bertrand Roquelaure,Alain Lachaux,A. Morali,Christophe Dupont,Chantal Maurage,Marie-Odile Husson,Philippe Barthélémy +13 more
TL;DR: This study shows that 1-week OAC triple therapy results in successful eradication of H pylori in 75% of children with gastritis.
Journal ArticleDOI
Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease.
Thierry Lamireau,Jean-Pierre Cézard,Alain Dabadie,Olivier Goulet,Alain Lachaux,Dominique Turck,Chantal Maurage,A. Morali,Etienne Sokal,Dominique Charles Belli,Joaquim Stoller,Samy Cadranel,J.-L. Giniès,S. Viola,F. Huet,Jane Languepin,C. Lenaerts,F. Bury,Jacques Sarles +18 more
TL;DR: Treatment with infliximab is well tolerated and effective in most children and adolescents with Crohn’s disease that is refractory to conventional immunosuppressive therapy and further studies are needed to precisely determine the best modality of continuing treatment.
Journal ArticleDOI
Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors
C. Lenaerts,Chantale Lapierre,Heidi Patriquin,Nathalie J. Bureau,Guy Lepage,François Harel,Jacques E. Marcotte,Claude C. Roy +7 more
TL;DR: Routine ultrasonography was an early marker of liver disease and more severe CF disease, a predictor of progressive liver disease, and a controlled trial should be done to assess isolated US-detected disease as an indication for UDCA.
Journal ArticleDOI
Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.
TL;DR: It is suggested that patients with intestinal obstruction are at greater risk for the development of cirrhosis and that strategies should be developed to increase the detergent capacity of bile and its flow in order to decrease the viscosity of mucus in the biliary tree.